Free Trial

Nature's Sunshine Products (NATR) Projected to Post Earnings on Tuesday

Nature's Sunshine Products logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Nature's Sunshine is expected to report results after the close on Tuesday, March 10, with analysts projecting $0.19 EPS and $121.62 million in revenue for the quarter.
  • The stock opened at $25.06, the company has a market cap of about $438.6 million and a P/E of 30.94, with 50‑day/200‑day SMAs of $24.77 and $20.19 and a 52‑week range of $11.01–$28.14.
  • Analysts have a consensus rating of Moderate Buy with an average price target of $22.50; insiders own 4.7% (including a recent EVP sale of 1,700 shares) and institutions hold roughly 79.4% of the stock.
  • MarketBeat previews the top five stocks to own by May 1st.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) is anticipated to post its results after the market closes on Tuesday, March 10th. Analysts expect Nature's Sunshine Products to post earnings of $0.19 per share and revenue of $121.6210 million for the quarter.

Nature's Sunshine Products Price Performance

NASDAQ:NATR opened at $25.06 on Friday. The company has a market capitalization of $438.55 million, a P/E ratio of 30.94 and a beta of 0.94. The business has a fifty day simple moving average of $24.77 and a two-hundred day simple moving average of $20.19. Nature's Sunshine Products has a 1 year low of $11.01 and a 1 year high of $28.14.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Weiss Ratings reiterated a "hold (c+)" rating on shares of Nature's Sunshine Products in a research note on Monday, December 29th. DA Davidson upped their price objective on shares of Nature's Sunshine Products from $21.00 to $23.00 and gave the company a "buy" rating in a report on Monday, November 10th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $22.50.

Read Our Latest Report on Nature's Sunshine Products

Insider Buying and Selling

In other news, EVP Bryant J. Yates sold 1,700 shares of the business's stock in a transaction on Friday, December 12th. The shares were sold at an average price of $22.29, for a total transaction of $37,893.00. Following the completion of the transaction, the executive vice president directly owned 98,604 shares in the company, valued at $2,197,883.16. The trade was a 1.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Nature's Sunshine Products

Several large investors have recently added to or reduced their stakes in NATR. Raymond James Financial Inc. bought a new stake in shares of Nature's Sunshine Products during the 2nd quarter valued at about $37,000. Centiva Capital LP purchased a new stake in Nature's Sunshine Products in the third quarter valued at approximately $157,000. Algert Global LLC purchased a new stake in Nature's Sunshine Products in the third quarter valued at approximately $160,000. Public Employees Retirement System of Ohio lifted its position in Nature's Sunshine Products by 76.9% during the third quarter. Public Employees Retirement System of Ohio now owns 10,791 shares of the company's stock valued at $167,000 after purchasing an additional 4,692 shares during the last quarter. Finally, Occudo Quantitative Strategies LP purchased a new position in Nature's Sunshine Products in the 3rd quarter worth approximately $173,000. Institutional investors own 79.40% of the company's stock.

About Nature's Sunshine Products

(Get Free Report)

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.

Recommended Stories

Earnings History for Nature's Sunshine Products (NASDAQ:NATR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nature's Sunshine Products Right Now?

Before you consider Nature's Sunshine Products, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.

While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines